Jim Cramer on CVS: "I Think It's a Fascinating Time to Own the Stock"

CVS Health Corporation (NYSE:CVS) is one of the stocks in focus on Jim Cramer’s game plan. Cramer highlighted the stock’s catalysts and the company CEO’s performance, as he commented:

On Tuesday, we’re back in heavy earnings rotation. We’ve got DuPont, Coca-Cola, CVS Health, AstraZeneca, Datadog, and S&P Global report… CVS is now less of a drug store than a managed care company, which is, theirs is called Aetna. The stock got hammered not that long ago, and we learned that the government will barely raise reimbursement rates for Medicare Advantage plans this year. It was a disaster for the health insurers.

The only one I want to own is CVS, which reports Tuesday morning. CEO David Joyner’s done a terrific job, and I think it’s a fascinating time to own the stock… You know what, they’re the last real national drugstore chain now that Walgreens has been taken private, and the one-time giant Rite Aid has closed all of its stores. Now, how do you like that?

CVS Health Corporation (NYSE:CVS) provides healthcare solutions through insurance, pharmacy benefit management, and retail pharmacy services.

While we acknowledge the potential of CVS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.